Navigation Links
Essilor's First-Half 2008 Results
Date:8/27/2008

>

- The buyback of 1.7 million Essilor shares for a total of

EUR64.5 million, increasing treasury stock from 1.3% to 2.0%.

Highlights since the end of the first half

Ongoing external growth strategy Since July 1, Essilor has acquired three new companies. In Germany, it acquired Nika GmbH, a lens wholesaler with around EUR9 million in revenue. In the United States, Essilor of America acquired a majority stake in Optimatrix, a prescription laboratory based in Alabama with revenue of $4.6 million. In India, Essilor acquired the assets of Sankar & Co's ophthalmic division, comprising five formerly franchised laboratories, which together generate EUR0.9 million in revenue.

Launch of a specific program to buy back 3.3% of outstanding shares

In July, Essilor decided to introduce a share buyback program to offset the dilutive impact of OCEANE bonds due in 2010 in the event that the remaining bonds are converted into new or existing shares.

The program consists of purchasing 6.9 million shares, or 3.3% of the capital. Financed by cash and routine borrowings, this investment will increase the Company's gearing.

Launched in July 2008, the buyback will continue through the end of the year and, if necessary, may extend into 2009.

In addition to this specific program, Essilor will continue to buy back shares to reduce the dilutive impact of stock option and performance share grants.

Outlook

In the second half, Essilor will pursue its strategy of deploying valued-added products, developing in the international marketplace and expanding through acquisitions. Full year performance is expected once again to confirm Essilor's ability to drive steady growth in both revenue and margins.

------------------------

A meeting with analysts will be held today at 10:00 a.m.

The meeting will be webcast live and recorded for later viewing at the following address:
'/>"/>

SOURCE Essilor
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Biopure Announces 2008 Third Quarter Financial Results
2. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
3. CEL-SCI CORPORATION Reports Third Quarter 2008 Financial Results
4. Arpida Reports Interim Results for Six Months to 30 June 2008
5. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
6. Rosetta Genomics Reports Second Quarter 2008 Financial Results
7. VNUS Corrects Second Quarter 2008 Results and Revises Full Year 2008 Guidance
8. Arno Therapeutics Announces Second Quarter 2008 Financial Results
9. Logical Therapeutics Inc. Announces Results of Phase 1b Clinical Study of its Naproxen Prodrug
10. Lotus Pharmaceuticals Announces Second Quarter 2008 Results
11. Yongye Biotechnology International Announces Second Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Diagenode, Inc., ... as the Bioruptor® and complete solutions for epigenetics ... chromatin immunoprecipitation, alleviating the need for manual processing. ... needed for ChIP of histones or transcription factors ...
(Date:1/22/2015)...  Derma Sciences, Inc. (Nasdaq: DSCI ), ... care, announces that AMNIOEXCEL® and AMNIOMATRIX®, amniotic allografts ... the Premier, Inc. Regenerative Skin Grafting contract portfolio. ... and AMNIOMATRIX® product lines, which continue to be ...
(Date:12/24/2014)... Dec. 24, 2014   BioLife Solutions , Inc. (NASDAQ: ... proprietary clinical grade hypothermic storage and cryopreservation ... for cells and tissues  ("BioLife" or the "Company"), today announced ... on May 4, 2015 (the "Annual Meeting"). Because ...
(Date:12/24/2014)... December 23, 2014 On Friday, December ... the Omnibus and Continuing Resolution Appropriations Act of 2015, ... eligible to receive funding through the Congressionally Directed Medical ... (DoD). The Hydrocephalus Association (HA), working in conjunction with ...
Breaking Biology Technology:Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5BioLife Solutions Sets Date for Annual Meeting of Stockholders 2Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... GENEVA, Sept. 11 Friendly LRL Holdings LLC ("FLH") ... to acquire all of the outstanding shares of common stock ... immediately. FLH,s offer was scheduled to expire at 11:59 ... All shares previously tendered pursuant to the tender offer ...
... ... a series of experiments to demonstrate the power of nanotechnology based regenerative medicines. ... (PRWEB) September 11, ... announced plans to attempt to rejuvenate living animals with advanced nanotechnologies developed by his ...
... HORSHAM, Pa., Sept. 10 Centocor Ortho Biotech Products, ... the U.S. Food and Drug Administration (FDA) regarding its Supplemental New ... in combination with docetaxel for the treatment of women ... , Centocor Ortho Biotech is evaluating the FDA,s letter ...
Cached Biology Technology:Friendly LRL Holdings Terminates Offer To Acquire Startech Environmental Corporation 2Friendly LRL Holdings Terminates Offer To Acquire Startech Environmental Corporation 3Matthew Sarad to Reverse Aging and Cure Cancer 2Matthew Sarad to Reverse Aging and Cure Cancer 3Matthew Sarad to Reverse Aging and Cure Cancer 4Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 2Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 3Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 4Centocor Ortho Biotech Receives FDA Complete Response Letter Regarding DOXIL(R) for the Treatment of Advanced Breast Cancer 5
(Date:1/22/2015)... 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading source of biometrics ... its new website design. "When we launched FindBiometrics ... Peter O,Neill , founder and CEO of FindBiometrics. "Now ... involvement from the key players on a very broad scale.  ...
(Date:1/22/2015)... DETROIT , Jan. 13, 2015 Technology Showcase, Hall ... iris-based identity authentication solutions, today announced it will showcase its ... and developed by the Department of Energy,s Oak Ridge ... International Auto Show . EyeLock,s iris identity authentication technology is ...
(Date:1/22/2015)... man-made form of insulin delivered by nasal spray may ... with mild cognitive impairment and Alzheimer,s disease dementia, according ... Forest Baptist Medical Center. The study,s subjects ... (MCI) or mild to moderate Alzheimer,s dementia (AD). Those ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... child could well be a ring of poison. ,Thats because ... cyanide to protect itself against little herbivores, such as ... that do not make cyanide are found in climates with ... and geography play important roles. ...
... reporting development of a fast, inexpensive test suitable for ... those out of the blue headaches that may follow ... aged or fermented foods. The test is ... naturally occurring toxins that can trigger a wide range ...
... University of Warwick have devised a means of identifying ... just a few seconds. Previous techniques have tried ... print and laboriously match them against a database of ... detailed pattern of each print and transform the topological ...
Cached Biology News:Genetic differences in clover make one type toxic 2Genetic differences in clover make one type toxic 3New test could help consumers avoid surprise headaches from chocolate, wine 2New test could help consumers avoid surprise headaches from chocolate, wine 3New technology identifies warped fingerprints at warp speed 2
Mouse monoclonal [3576] to Yellow Fever Virus ( Abpromise for all tested applications). Antigen: Tissue / cell preparation...
... Each Signet Level 2 Detection ... the avidin-biotin chemical bonding principle and ... to provide sensitivity, specificity and reliablility. ... immunostaining in both manual and automated ...
6X DNA Gel Loading Buffer is intended for gel electrophoresis of DNA fragments or PCR products....
Agarose Gel Loading Dye Mixture 6X...
Biology Products: